First, allocable interest deductions for any LLY
cannot exceed the excess of the amount allowable as a deduction for interest paid or accrued by the taxpayer during the LLY
, over the average of such amounts for the three tax years preceding the tax year in which the CERT occurred.
's CEO says, "Lawyers are wrongly blaming the drug maker in the case of a pharmacist charged with diluting chemotherapy drugs"  Does this statement make it appear that LLY
is attempting to fend off a legal challenge while disclaiming responsibility to patients?